AstraZeneca PLC Ordinary Shares (AZN)
Goodwill
$21.16B
Quarterly · Period ending: · USD

AZN Goodwill
Latest reported$21.16Bperiod ending
Latest reported$21.16Bperiod ending
AZN Quarterly Goodwill ($0.00 → $21.16B)
Quarterly goodwill
High-resolution chart · PNG
AZN goodwill history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Goodwill (USD) |
|---|---|
| 21,156,264,000 | |
| 21,194,000,000 | |
| 21,242,000,000 | |
| 21,219,000,000 | |
| 21,222,000,000 | |
| 21,130,000,000 | |
| 21,025,000,000 | |
| 21,139,000,000 | |
| 21,060,000,000 | |
| 19,978,000,000 | |
| 20,048,000,000 | |
| 19,939,000,000 | |
| 19,960,000,000 | |
| 20,001,000,000 | |
| 19,820,000,000 | |
| 19,707,000,000 | |
| 19,821,000,000 | |
| 19,963,000,000 | |
| 19,997,000,000 | |
| 20,081,000,000 | |
| 11,798,000,000 | |
| 11,765,000,000 | |
| 11,845,000,000 | |
| 11,711,000,000 | |
| 11,645,000,000 | |
| 11,569,000,000 | |
| 11,668,000,000 | |
| 11,595,000,000 | |
| 11,668,000,000 | |
| 11,674,000,000 | |
| 11,707,000,000 | |
| 11,729,000,000 | |
| 11,717,000,000 | |
| 11,834,000,000 | |
| 11,825,000,000 | |
| 11,841,000,000 | |
| 11,774,000,000 | |
| 11,688,000,000 | |
| 11,658,000,000 | |
| 11,806,000,000 | |
| 11,848,000,000 | |
| 11,988,000,000 | |
| 11,868,000,000 | |
| 11,430,000,000 | |
| 11,467,000,000 | |
| 11,387,000,000 | |
| 11,550,000,000 | |
| 11,368,000,000 | |
| 11,560,000,000 | |
| 11,601,000,000 | |
| 9,981,000,000 | |
| 9,943,000,000 | |
| 9,958,000,000 | |
| 9,881,000,000 | |
| 9,898,000,000 | |
| 9,898,000,000 | |
| 9,887,000,000 | |
| 9,871,000,000 | |
| 9,862,000,000 | |
| 9,874,000,000 | |
| 9,877,000,000 | |
| 9,890,000,000 | |
| 9,871,000,000 | |
| 9,878,000,000 | |
| 9,846,000,000 | |
| 9,866,000,000 | |
| 9,889,000,000 | |
| 9,893,000,000 | |
| 9,887,000,000 | |
| 9,855,000,000 | |
| 9,874,000,000 | |
| 9,870,000,000 | |
| 9,903,000,000 | |
| 9,906,000,000 | |
| 9,884,000,000 | |
| 9,713,000,000 | |
| 9,698,000,000 | |
| 1,102,000,000 | |
| 1,097,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |